Research ArticleOriginal Article
Open Access

Performance of dialysis patients on the standard and basic Arabic versions of the Montreal Cognitive Assessments

Taim A. Muayqil, Ahmad R. Tarakji, Abdullah M. Khattab, Nasser T. Balbaid, Ahmad M. Al-Dawalibi, Sami A. Alqarni, Reema A. Hazazi and Mohammed H. Alanazy
Neurosciences Journal April 2023, 28 (2) 100-107; DOI: https://doi.org/10.17712/nsj.2023.2.20220110

References

  1. 1.↵
    1. Mishra N,
    2. Mohan D,
    3. Fuad S,
    4. Basavanagowda DM,
    5. Alrashid ZA,
    6. Kaur A, et al.
    The Association Between Hypertension and Cognitive Impairment, and the Role of Antihypertensive Medications: A Literature Review. Cureus 2020; 12: e12035.
    OpenUrl
  2. 2.↵
    1. Carson N,
    2. Leach L,
    3. Murphy KJ.
    A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry 2018; 33: 379–388.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Paraizo Mde A,
    2. Almeida AL,
    3. Pires LA,
    4. Abrita RS,
    5. Crivellari MH,
    6. Pereira Bdos S, et al.
    [Montreal Cognitive Assessment (MoCA) screening mild cognitive impairment in patients with chronic kidney disease (CKD) pre-dialysis]. J Bras Nefrol 2016; 38: 31–41. Portuguese
    OpenUrl
  4. 4.↵
    1. Shea YF,
    2. Lam MF,
    3. Lee MS,
    4. Mok MY,
    5. Lui SL,
    6. Yip TP, et al.
    Prevalence of Cognitive Impairment Among Peritoneal Dialysis Patients, Impact on Peritonitis and Role of Assisted Dialysis. Perit Dial Int 2016; 36: 284–290.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Lu R,
    2. Xu C,
    3. Li Y,
    4. Yu L,
    5. Shao X,
    6. Xie K, et al.
    The Incidence Prognosis and Risk Factors of Cognitive Impairment in Maintenance Haemodialysis Patients. Blood Purif 2019; 47: 101–108.
    OpenUrlPubMed
  6. 6.↵
    1. Nasreddine ZS,
    2. Phillips NA,
    3. Bedirian V,
    4. Charbonneau S,
    5. Whitehead V,
    6. Collin I, et al.
    The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 2005; 53: 695–699.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Nicholas P,
    2. Green T,
    3. Purtell L,
    4. Bonner A.
    A cross-sectional study exploring cognitive impairment in kidney failure. J Ren Care 2022; 48: 93–101.
    OpenUrl
  8. 8.↵
    1. Kalirao P,
    2. Pederson S,
    3. Foley RN,
    4. Kolste A,
    5. Tupper D,
    6. Zaun D, et al.
    Cognitive impairment in peritoneal dialysis patients. Am J Kidney Dis 2011; 57: 612–620.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Adlimoghaddam A,
    2. Roy B,
    3. Albensi BC.
    Future Trends and the Economic Burden of Dementia in Manitoba: Comparison with the Rest of Canada and the World. Neuroepidemiology 2018; 51: 71–81.
    OpenUrl
  10. 10.
    1. Guenzani D,
    2. Buoli M,
    3. Caldiroli L,
    4. Carnevali GS,
    5. Serati M,
    6. Vezza C, et al.
    Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease. J Psychosom Res 2019; 124: 109783.
    OpenUrl
  11. 11.↵
    1. Muayqil TA,
    2. Tarakji AR,
    3. Khattab AM,
    4. Balbaid NT,
    5. Al-Dawalibi AM,
    6. Alqarni SA, et al.
    Comparison of Performance on the Clock Drawing Test Using Three Different Scales in Dialysis Patients. Behav Neurol 2020; 2020: 7963837.
  12. 12.↵
    1. Salazar-Felix NA,
    2. Martin-Del-Campo F,
    3. Cueto-Manzano AM,
    4. Romo-Flores ML,
    5. Velazquez-Vidaurri AL,
    6. Sanchez-Soriano A, et al.
    Prevalence of mild cognitive impairment in automated peritoneal dialysis patients 2021. Nephrol Dial Transplant 2021; 36: 2106–2111.
    OpenUrl
  13. 13.
    1. Chalhoub NE,
    2. Luggen ME.
    Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly. Lupus 2019; 28: 51–58.
    OpenUrl
  14. 14.↵
    1. Drew DA,
    2. Weiner DE,
    3. Sarnak MJ.
    Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention. Am J Kidney Dis 2019; 74: 782–790.
    OpenUrlPubMed
  15. 15.↵
    1. Cui L,
    2. Chen W,
    3. Yu X,
    4. Ju C.
    The relationship between cognitive function and having diabetes in patients treated with hemodialysis. Int J Nurs Sci 2020; 7: 60–65.
    OpenUrl
  16. 16.↵
    1. Tamura MK,
    2. Yaffe K.
    Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int 2011; 79: 14–22.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Lee SH,
    2. Cho A,
    3. Min YK,
    4. Lee YK,
    5. Jung S.
    Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms. Renal Failure 2018; 40: 323–330.
    OpenUrl
  18. 18.↵
    1. Neumann D,
    2. Mau W,
    3. Wienke A,
    4. Girndt M.
    Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course. Kidney Int 2018; 93: 430–438.
    OpenUrlPubMed
  19. 19.↵
    1. Shin DJ,
    2. Kim T,
    3. Jung DU,
    4. Moon JJ,
    5. Jeon DW,
    6. Kim SJ, et al.
    Association between Dialysis Adequacy and Cognition in Patients with Peritoneal Dialysis. Psychiatry Investig 2020; 17: 1143–1148.
    OpenUrl
  20. 20.
    1. Julayanont P,
    2. Tangwongchai S,
    3. Hemrungrojn S,
    4. Tunvirachaisakul C,
    5. Phanthumchinda K,
    6. Hongsawat J, et al.
    The Montreal Cognitive Assessment-Basic: A Screening Tool for Mild Cognitive Impairment in Illiterate and Low-Educated Elderly Adults. Neurology 2015; 63: 2550–2554.
    OpenUrl
  21. 21.
    1. Angermann S,
    2. Schier J,
    3. Baumann M,
    4. Steubl D,
    5. Hauser C,
    6. Lorenz G, et al.
    Cognitive Impairment is Associated with Mortality in Hemodialysis Patients. J Alzheimers Dis 2018; 66: 1529–1537.
    OpenUrl
  22. 22.
    1. Hu MT,
    2. Szewczyk-Krolikowski K,
    3. Tomlinson P,
    4. Nithi K,
    5. Rolinski M,
    6. Murray C, et al.
    Predictors of cognitive impairment in an early stage Parkinson’s disease cohort. Mov Disord 2014; 29: 351–359.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Luo Y,
    2. Murray AM,
    3. Guo YD,
    4. Tian R,
    5. Ye PP,
    6. Li X, et al.
    Cognitive impairment and associated risk factors in older adult hemodialysis patients: a cross-sectional survey. Front Neurol 2020; 10: 12542.
    OpenUrl
  24. 24.↵
    1. Stolwyk RJ,
    2. O’Neill MH,
    3. McKay AJ,
    4. Wong DK.
    Are cognitive screening tools sensitive and specific enough for use after stroke? A systematic literature review. Stroke 2014; 45: 3129–3134.
    OpenUrlFREE Full Text
  25. 25.↵
    1. Guerville F,
    2. De Souto Barreto P,
    3. Coley N,
    4. Andrieu S,
    5. Mangin JF,
    6. Chupin M, et al.
    Kidney Function and Cognitive Decline in Older Adults: Examining the Role of Neurodegeneration. J Am Geriatr Soc 2021; 69: 651–659.
    OpenUrl
  26. 26.↵
    1. Palta P,
    2. Carlson MC,
    3. Crum RM,
    4. Colantuoni E,
    5. Sharrett AR,
    6. Yasar S, et al.
    Diabetes and Cognitive Decline in Older Adults: The Ginkgo Evaluation of Memory Study. J Gerontol A Biol Sci Med Sci 2018; 73: 123–130.
    OpenUrl
  27. 27.↵
    1. Lu R,
    2. Xu C,
    3. Li Y,
    4. Yu L,
    5. Shao X,
    6. Xie K, et al.
    The Incidence Prognosis and Risk Factors of Cognitive Impairment in Maintenance Haemodialysis Patients. Blood Purification 2019; 47: 101–108.
    OpenUrlPubMed
  28. 28.
    1. Drew DA,
    2. Tighiouart H,
    3. Rollins J,
    4. Duncan S,
    5. Babroudi S,
    6. Scott T, et al.
    Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis. J Am Soc Nephrol 2020; 31: 855–864.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Thomann AE,
    2. Berres M,
    3. Goettel N,
    4. Steiner LA,
    5. Monsch AU.
    Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment. Alzheimers Res Ther 2020; 12: 39.
    OpenUrlPubMed
  30. 30.↵
    1. Kurella Tamura M,
    2. Larive B,
    3. Unruh ML,
    4. Stokes JB,
    5. Nissenson A,
    6. Mehta RL, et al.
    Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol. 2010; 5: 1429–1438.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Muayqil TA,
    2. Alamri NK,
    3. Alqahtani AM,
    4. Julaidan SS,
    5. Alsuhaibani R,
    6. Nafisah I, et al.
    Normative and Equated Data of the Original and Basic Versions of the Montreal Cognitive Assessment among Community Dwelling Saudi Arabians. Behav Neurol 2021; 2021: 5395627.
  32. 32.↵
    1. Zheng K,
    2. Wang H,
    3. Hou B,
    4. You H,
    5. Yuan J,
    6. Luo K, et al.
    Malnutrition-inflammation is a risk factor for cerebral small vessel diseases and cognitive decline in peritoneal dialysis patients: a cross-sectional observational study. BMC Nephrol 2017; 18: 366.
    OpenUrl
  33. 33.↵
    1. Amatneeks TM,
    2. Hamdan AC.
    Sensitivity and specificity of the Brazilian version of the Montreal Cognitive Assessment - Basic (MoCA-B) in chronic kidney disease. Trends Psychiatry Psychother 2019; 41: 327–333.
    OpenUrl
  34. 34.↵
    Statistics SG authority for. Demography survey. Saudi Arabia: 2016. From: https://www.stats.gov.sa/sites/default/files/en-demographic-research-2016_2.pdf
  35. 35.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR.
    “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Bruijnen CJWH,
    2. Dijkstra BAG,
    3. Walvoort SJW,
    4. Markus W,
    5. VanDerNagel JEL,
    6. Kessels RPC, et al.
    Prevalence of cognitive impairment in patients with substance use disorder. Drug Alcohol Rev 2019; 38: 435–442.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Gavrilovic A,
    2. Toncev G,
    3. Boskovic Matic T,
    4. Vesic K,
    5. Ilic Zivojinovic J,
    6. Gavrilovic J.
    Impact of epilepsy duration, seizure control and EEG abnormalities on cognitive impairment in drug-resistant epilepsy patients. Acta Neurol Belg. 2019; 119: 403–410.
    OpenUrl
  38. 38.↵
    1. Murray AM,
    2. Tupper DE,
    3. Knopman DS,
    4. Gilbertson DT,
    5. Pederson SL,
    6. Li S, et al.
    Cognitive impairment in hemodialysis patients is common. Neurology 2006; 67: 216–223.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Hussien H,
    2. Apetrii M,
    3. Covic A.
    Health-related quality of life in patients with chronic kidney disease. Expert Rev Pharmacoecon Outcomes Res 2021; 21: 43–54.
    OpenUrl
  40. 40.↵
    1. O’Driscoll C,
    2. Shaikh M.
    Cross-Cultural Applicability of the Montreal Cognitive Assessment (MoCA): A Systematic Review. J Alzheimers Dis 2017; 58: 789–801.
    OpenUrl
  41. 41.↵
    1. Wong A,
    2. Xiong YY,
    3. Kwan PW,
    4. Chan AY,
    5. Lam WW,
    6. Wang K, et al.
    The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dement Geriatr Cogn Disord 2009; 28: 81–87.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Milani SA,
    2. Marsiske M,
    3. Cottler LB,
    4. Chen X,
    5. Striley CW.
    Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity. Alzheimers Dement (Amst) 2018; 10: 773–781.
    OpenUrlCrossRef
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section